• Investing Ideas
  • /
  • U.S. Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20
Header cover image

U.S. Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20

A list of companies that grew earnings by 20% and are trading on less than 20 times earnings. All with a debt to equity ratio below 1.

2 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
BIOQBioqualUS$84.5017.4%24.3%US$75.6mn/aP/E11.9xn/a1.5%
PBSVPharma-Bio ServUS$1.00-11.5%-13.0%US$23.0mUS$2.11P/E7.9xS10.3%0%
Page 1 of 1